Judge Dismisses Shareholder Action Over Pharma Company’s Marketing of Opioid Treatment Drug

(CN) – A New York District judge granted pharmaceutical company Alkermes PLC’s motion to dismiss a shareholder class action alleging the company misrepresented sales figures and comparative effectiveness for a drug developed to treat opioid dependence.

Read more